IN2015DN02358A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02358A
IN2015DN02358A IN2358DEN2015A IN2015DN02358A IN 2015DN02358 A IN2015DN02358 A IN 2015DN02358A IN 2358DEN2015 A IN2358DEN2015 A IN 2358DEN2015A IN 2015DN02358 A IN2015DN02358 A IN 2015DN02358A
Authority
IN
India
Prior art keywords
medicaments
cosmetics
synthesis
subject
formula
Prior art date
Application number
Other languages
English (en)
Inventor
Pietro Antonino; Di
Francesca; Cavazza
Paolo; Caliceti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47022522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN02358(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of IN2015DN02358A publication Critical patent/IN2015DN02358A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
IN2358DEN2015 2012-10-09 2013-10-07 IN2015DN02358A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12187828 2012-10-09
PCT/EP2013/070814 WO2014056841A1 (en) 2012-10-09 2013-10-07 Modified hyaluronic acid derivatives and use thereof

Publications (1)

Publication Number Publication Date
IN2015DN02358A true IN2015DN02358A (cg-RX-API-DMAC7.html) 2015-09-04

Family

ID=47022522

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2358DEN2015 IN2015DN02358A (cg-RX-API-DMAC7.html) 2012-10-09 2013-10-07

Country Status (21)

Country Link
US (1) US20150252120A1 (cg-RX-API-DMAC7.html)
EP (1) EP2906193B1 (cg-RX-API-DMAC7.html)
JP (1) JP2015533190A (cg-RX-API-DMAC7.html)
KR (1) KR20150065861A (cg-RX-API-DMAC7.html)
CN (1) CN104703583A (cg-RX-API-DMAC7.html)
AR (1) AR092922A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013328842A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015007823A2 (cg-RX-API-DMAC7.html)
CA (1) CA2886144A1 (cg-RX-API-DMAC7.html)
CL (1) CL2015000803A1 (cg-RX-API-DMAC7.html)
EA (1) EA201590708A1 (cg-RX-API-DMAC7.html)
HK (1) HK1210941A1 (cg-RX-API-DMAC7.html)
IL (1) IL238103A0 (cg-RX-API-DMAC7.html)
IN (1) IN2015DN02358A (cg-RX-API-DMAC7.html)
MX (1) MX2015004386A (cg-RX-API-DMAC7.html)
PE (1) PE20150713A1 (cg-RX-API-DMAC7.html)
PH (1) PH12015500585A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201501992XA (cg-RX-API-DMAC7.html)
TW (1) TW201414478A (cg-RX-API-DMAC7.html)
WO (1) WO2014056841A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201503171B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI614005B (zh) * 2014-05-26 2018-02-11 National Taipei University Of Technology 水膠組合物的用途
DE202014008682U1 (de) * 2014-07-11 2015-08-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Magenbeschwerden
EP3397241A1 (en) * 2015-12-30 2018-11-07 Asafov, Alexander Vilenovich Formulation for treatment of peripheral joints, spinal joints and/or extracellular matrix elements of connective tissue, method of manufacture and uses
RU2625766C1 (ru) * 2016-07-19 2017-07-18 Александр Ливиевич Ураков Средство для экстренного восстановления голоса при внезапной афонии
CN116891540A (zh) * 2018-03-22 2023-10-17 持田制药株式会社 连接有非甾体抗炎化合物的海藻酸衍生物
EP3793525A4 (en) * 2018-05-16 2022-02-16 Emory University PALLADIUM HYALURONIC ACID PARTICLES AND METHODS OF MANAGEMENT OF CANCER OR ANGIOGENIC DISEASES
CN119176959B (zh) * 2024-09-18 2025-07-04 云南贝泰妮生物科技集团股份有限公司 一种透明质酸-聚乳酸共聚物交联凝胶及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
GB8713662D0 (en) 1987-06-11 1987-07-15 Skandigen Ab Hyaluronic acid derivatives
US4839159A (en) 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
IT1251151B (it) 1991-08-05 1995-05-04 Fidia Spa Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US6585987B1 (en) 1998-11-13 2003-07-01 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
CA2445985A1 (en) 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
ITMI20021666A1 (it) 2002-07-26 2004-01-26 Jasper Ltd Liability Co Derivati dell'acido ialuronico
US20110027357A1 (en) * 2004-02-18 2011-02-03 Isaac Gilinski Compositions and methods for timed release of water-soluble nutritional supplements
US20060134147A1 (en) 2004-12-21 2006-06-22 Avon Products, Inc. Cosmetic compositions having carnitine creatinate and methods for using
CA2593064A1 (en) 2004-12-30 2006-07-06 Novozymes Biopolymer A/S Hyaluronic acid linked with a polymer of an alpha hydroxy acid
JP5047507B2 (ja) * 2005-09-30 2012-10-10 昭和電工株式会社 カルニチン誘導体及びその塩、皮膚外用剤ならびに化粧料
ITMI20052035A1 (it) 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
EP1884231A1 (en) 2006-08-01 2008-02-06 Auriga International S.A. Cosmetic or pharmaceutical composition containing hyaluronic acid
CN101677912B (zh) 2007-05-11 2013-06-12 希格马托制药工业公司 可用于递送化妆品活性成分的凝胶
EP2162158A2 (en) 2007-05-23 2010-03-17 Allergan, Inc. Coated hyaluronic acid particles
WO2010003797A1 (en) 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing

Also Published As

Publication number Publication date
EP2906193B1 (en) 2016-09-28
TW201414478A (zh) 2014-04-16
CA2886144A1 (en) 2014-04-17
KR20150065861A (ko) 2015-06-15
BR112015007823A2 (pt) 2017-07-04
JP2015533190A (ja) 2015-11-19
US20150252120A1 (en) 2015-09-10
HK1210941A1 (en) 2016-05-13
ZA201503171B (en) 2016-11-30
AU2013328842A1 (en) 2015-04-09
PE20150713A1 (es) 2015-05-16
PH12015500585A1 (en) 2015-05-04
SG11201501992XA (en) 2015-04-29
EP2906193A1 (en) 2015-08-19
WO2014056841A1 (en) 2014-04-17
AR092922A1 (es) 2015-05-06
IL238103A0 (en) 2015-05-31
CL2015000803A1 (es) 2015-08-07
CN104703583A (zh) 2015-06-10
MX2015004386A (es) 2015-06-10
EA201590708A1 (ru) 2015-07-30

Similar Documents

Publication Publication Date Title
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
GB201106743D0 (en) Novel compounds
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX343706B (es) Derivados heterocíclicos novedosos.
NZ603151A (en) N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
PH12015501083B1 (en) Novel pyridine derivatives
IN2015DN01119A (cg-RX-API-DMAC7.html)
MY179412A (en) Pyridine-2-amides useful as cb2 agonists
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
PH12015500585A1 (en) Modified hyaluronic acid derivatives and use thereof
IN2014DN06104A (cg-RX-API-DMAC7.html)
IN2015DN03998A (cg-RX-API-DMAC7.html)
MY182328A (en) Pyridine-2-amides useful as cb2 agonists
MX2015004362A (es) Derivados de ketamina.
IN2014DN10449A (cg-RX-API-DMAC7.html)
MX2014004920A (es) Nuevos derivados de pirazina.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
TR201903918T4 (tr) Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.
MX348841B (es) Derivados de pirimidooxazocina como inhibidores de mtor.
WO2011107866A3 (en) Silyl-derivatives of polysaccharides
MX365192B (es) Derivados de bendamustina y compuestos relacionados, y uso medico de los mismos para la terapia de cancer.
PH12015500262A1 (en) Novel pyridine derivatives
IN2015MN00091A (cg-RX-API-DMAC7.html)
MX351093B (es) Nuevos derivados de azetidina.